Selected 2004 Licensing and Technology Transactions

Download IconDownload Print IconPrint

Selected 2004 Licensing and Technology Transactions

Publication

Related Documents

Related Solutions

Our China Trade Practice offers a unique combination of services bringing together prominent policy, regulatory and government relations capabilities in China with premier in-country business and transactions experience.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Our clients in the ever-changing and fiercely competitive hardware, software, IT and services industries depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and preserving flexibility for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale’s unique capabilities in regulatory, intellectual property, corporate and tax law. We represent both mature and emerging companies with business models centered around offering software and/or professional services relating to analyzing and extracting insights from large data sets. We frequently draft and negotiate data license agreements, software-as-a-service (SaaS) agreements, website terms and other services agreements in which data is the core subject of the license. We also advise technology clients on big data issues that arise in outsourcing, joint venture and other transactional matters. Our attorneys keep a close watch on internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.

In 2004, our corporate, licensing and intellectual property lawyers handled hundreds of licensing, product development, outsourcing, manufacturing, distribution, joint venture, strategic alliance and similar agreements, including deals that are helping to shape the future of science and technology. In recent years, we have advised clients on strategic alliances that have received industry recognition for their importance, and our lawyers have been recognized as global leaders in this field. Selected transactions from 2004 are listed below:

  • Achillion Pharmaceuticals — Collaboration with Gilead for the development and commercialization of Achillion's hepatitis C compounds
  • America Online — Exclusive payment processing agreement with Paymentech
  • Analog Devices— Product development, supply, OEM and license agreements
  • ASML — Strategic alliance with IBM and SUNY for advanced semiconductor lithography equipment
  • Bayer — License of liposome technology from Zilip-Pharma for use in Kogenate® hemophilia product
  • Bose— Agreements for international distribution of premier sound systems
  • Caprion — Lung cancer drug discovery collaboration with Abbott Laboratories
  • Columbia University — Licensing of thin film display technology to major Asian electronics manufacturers
  • Curis— Strategic partnership with Wyeth to develop therapeutics for neurological disorders
  • Diners Club International — Alliance with MasterCard for domestic and international transaction processing
  • DoubleClick — Alliance for integration of Omniture analytics solution with DoubleClick products
  • ETS— Outsourcing agreement with Thomson Prometric for computerized educational testing services
  • Hybridon— Research collaboration with Lexicon Genetics
  • IETF— Intellectual property advice for the leading Internet standards body
  • Icagen— Development and commercialization agreement with McNeil for treatment of sickle cell disease
  • IMlogic— Collaboration with AOL to provide instant messaging support services
  • Infinity Pharmaceuticals — Small molecule alliances with Johnson & Johnson and Novartis
  • KB Toys — Exclusive agreement with WiseBuys for retail toy distribution
  • Mentasys — Worldwide software license agreement with eBay
  • Mentor Graphics — Advice on international software licensing transactions
  • Microbia — Biomanufacturing alliances with leading drug and chemical manufacturers
  • Millennium Pharmaceuticals— License agreement with GlaxoSmithKline for exclusive European rights to heart drug Integrilin
  • MKS Instruments— Alliance for resale of Umetrics’ products into semiconductor market
  • Myrio — Worldwide OEM agreement with Siemens
  • NFL — Advice on various television broadcast issues
  • O2 — Strategic agreement with NTT Docomo for mobile Internet service technology in the UK, Germany and Ireland
  • Pronova Biocare — US license and supply agreement with Reliant Pharmaceuticals for Omacor® product
  • Public Interest Registry— Advice to .org Internet domain registry
  • RedHat — Establishment of South American distribution channel
  • SemBioSys — Agreement with Dow AgroSciences for collaborative research
  • SmartBargains— Agreements with online merchants for B2C shopping portal
  • Starent Networks— Product supply and OEM agreements with major U.S. and European telecom companies
  • Syngenta — Advice on licensing and distribution matters
  • TargetRx— Marketing information engagements by major pharmaceutical companies
  • Wyeth — Sale to Genzyme of commercialization rights to Synvisc® pain relief product
  • WebMD — Search and health-related sponsored advertising agreement with Google

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel